Alberto Zanetto Selected Research

Alberto Zanetto Research Topics

Disease

39	Fibrosis (Cirrhosis) 03/2024 - 01/2015
22	Liver Diseases (Liver Disease) 03/2024 - 09/2014
14	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 01/2015
9	Hemorrhage 01/2023 - 10/2020
8	End Stage Liver Disease 02/2024 - 01/2016
8	Infections 01/2023 - 09/2014
6	Thrombosis (Thrombus) 11/2023 - 12/2018
6	Neoplasms (Cancer) 01/2022 - 01/2015
5	Inflammation (Inflammations) 11/2023 - 01/2015
5	Thrombophilia 01/2023 - 11/2018
4	Bacterial Infections (Bacterial Infection) 03/2024 - 02/2018
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2015
4	Portal Hypertension 12/2022 - 12/2016
4	Hepatitis B 06/2018 - 01/2015
4	Chronic Hepatitis C 01/2018 - 09/2014
3	Ascites 01/2023 - 01/2018
3	Sarcopenia 01/2023 - 03/2021
3	Liver Neoplasms (Liver Cancer) 04/2022 - 01/2017
3	Hepatitis C 04/2022 - 01/2017
3	Virus Diseases (Viral Diseases) 01/2018 - 01/2017
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2023
2	Reinfection 01/2023 - 01/2016
2	Disease Progression 01/2023 - 01/2023
2	Malnutrition (Nutritional Deficiencies) 10/2022 - 03/2021
2	Thrombocytosis (Thrombocythemia) 01/2022 - 11/2018
2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 01/2021 - 01/2019
2	Alcoholic Liver Diseases (Alcoholic Liver Disease) 02/2018 - 01/2016
2	Alcoholic Hepatitis 01/2017 - 01/2016
2	Hepatitis 01/2016 - 01/2015
1	COVID-19 11/2023
1	Esophageal and Gastric Varices (Esophageal Varices) 11/2023
1	Acute Kidney Injury (Acute Renal Failure) 02/2023
1	Thrombocytopenia (Thrombopenia) 02/2023
1	Fatty Liver 01/2023
1	Hepatic Encephalopathy 01/2023
1	Obesity 01/2023
1	Frailty 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Vitamin D Deficiency 10/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 11/2021
1	Chemical and Drug Induced Liver Injury 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021

Drug/Important Bio-Agent (IBA)

17	Antiviral Agents (Antivirals)IBA 11/2023 - 09/2014
7	Thrombin FDA Link 10/2023 - 12/2018
6	Hemostatics (Antihemorrhagics)IBA 03/2024 - 11/2018
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2022
5	von Willebrand FactorIBA 03/2024 - 10/2020
5	InterferonsIBA 04/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 03/2021 - 01/2015
4	ThrombomodulinIBA 10/2023 - 10/2021
4	AnticoagulantsIBA 07/2022 - 12/2018
3	Thromboplastin (Tissue Factor)IBA 01/2022 - 11/2018
2	hepatitis B hyperimmune globulinIBA 01/2023 - 06/2018
2	Antifibrinolytic Agents (Antifibrinolytics)IBA 01/2023 - 12/2021
2	Blood Coagulation Factors (Coagulation Factor)IBA 01/2023 - 10/2020
2	CreatinineIBA 01/2023 - 01/2021
2	Fibrinolysin FDA Link 01/2023 - 12/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 06/2018
2	Plasminogen Activator Inhibitor 1IBA 01/2023 - 01/2022
2	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2022 - 01/2021
2	Fibrinogen (Factor I)FDA Link 01/2022 - 11/2018
1	Thrombopoietin (c-mpl Ligand)IBA 03/2024
1	Phospholipids (Phosphatides)FDA LinkGeneric 03/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2023
1	C-Reactive ProteinIBA 01/2023
1	PlasminogenIBA 07/2022
1	Fetal Proteins (Fetoprotein)IBA 04/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2022
1	AlbuminsIBA 04/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 12/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2021
1	Fondaparinux (Arixtra)FDA Link 10/2021
1	Amino Acids FDA Link 03/2021
1	Hormones (Hormone)IBA 03/2021
1	VitaminsIBA 03/2021
1	AmmoniaIBA 03/2021
1	MyostatinIBA 03/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Hepatitis B e AntigensIBA 01/2021
1	AntithrombinsIBA 10/2020
1	Factor VIII (Coagulation Factor VIII)IBA 10/2020
1	Protein CIBA 10/2020
1	Protein SIBA 10/2020
1	Factor XIII (Coagulation Factor XIII)IBA 10/2020
1	LipopolysaccharidesIBA 08/2020
1	GlycosaminoglycansIBA 08/2020

Therapy/Procedure

34	Liver Transplantation 02/2024 - 01/2016
16	Therapeutics 01/2023 - 09/2014
8	Transplantation 01/2023 - 01/2016
4	Surgical Portasystemic Shunt (Portosystemic Shunt) 01/2023 - 01/2021
3	Transjugular Intrahepatic Portasystemic Shunt 01/2023 - 08/2021
2	Stents 01/2023 - 12/2016
2	Contraindications 01/2021 - 01/2016
2	Aftercare (After-Treatment) 01/2020 - 12/2018
1	Length of Stay 10/2022
1	Radiofrequency Ablation 11/2021
1	Argon Plasma Coagulation 11/2021
1	Immunotherapy 01/2021